**Core Concept**
The management of Polycystic Ovary Syndrome (PCOS) with hirsutism involves hormonal therapies that target androgen excess. The goal is to regulate menstrual cycles, reduce androgen levels, and improve symptoms such as hirsutism.
**Why the Correct Answer is Right**
The combination of Ethinyl estradiol and Cyproterone Acetate is a standard treatment for PCOS with hirsutism. Ethinyl estradiol, a synthetic estrogen, helps regulate menstrual cycles and reduce androgen levels. Cyproterone Acetate, a synthetic progestin with anti-androgenic properties, blocks the effects of androgens on the skin, leading to reduced hirsutism. This combination effectively addresses both the hormonal imbalance and the symptom of hirsutism.
**Why Each Wrong Option is Incorrect**
**Option A:** Ethinyl estradiol alone may regulate menstrual cycles but does not address the issue of hirsutism directly.
**Option C:** Levonorgestrel, a progestin-only contraceptive, may worsen hirsutism due to its androgenic effects.
**Option D:** Ethinyl estradiol + Levonorgestrel may regulate menstrual cycles but does not have anti-androgenic effects to address hirsutism.
**Clinical Pearl / High-Yield Fact**
When managing PCOS with hirsutism, it is essential to consider the anti-androgenic effects of the treatment. Cyproterone Acetate is a key component in addressing hirsutism, and its combination with Ethinyl estradiol provides a balanced approach to hormonal regulation.